Global Immunochemistry Market

Immunochemistry Comprehensive Study by Type (Antibodies (Primary Antibodies and Secondary Antibodies), Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others), Reagents (Histological Stains, Blocking sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents), Kits), Application (Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases), Drug Testing), End-users (Hospitals & Diagnostic Laboratories, Research Institutes, Others) Players and Region - Global Market Outlook to 2028

Immunochemistry Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 7.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Immunochemistry is the study of the molecular mechanisms underlying the function of the immune system, especially the nature of antibodies, antigens, and their interactions. It has numerous applications in life sciences such as the use of antibodies for the labeling and detection of biomolecules in techniques such as ELISA, immunocytochemistry, and immunohistochemistry. According to AMA Research, the market for Immunochemistry is expected to register a CAGR of 7.9% during the forecast period to 2028. This growth is primarily driven by Increased Applications of Biochemistry in Life Science .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Billion)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Biotechnology sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, InC., Danaher (United States), Bio SB, Inc (United States), Becton, Dickinson and Company (United States), Merck KGaA (Germany), Biocare Medical, LLC., Abcam plc (United Kingdom) and Bio-Rad Laboratories (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In August 2021, Roche announced the FDA approval of its VENTANA MMR RxDx Panel. It can be used as a diagnostic aid to identify solid tumors and deficient DNA mismatch repair in patients. This test panel of MMR proteins in solid tumors helps to gather treatment information.
In May 2022, Agilent Technologies Inc., a leading manufacturer of analytical instrumentation announced that its PD-L1 IHC 22C3 pharmDx received EU CE-IVD for use in cervical cancer. PD-L1 IHC 22C3 pharmDx is used for identifying cervical cancer patients with PD-L1 CPS ≥ 1 for treatment with KEYTRUDA, which is developed by Merck.The companies are exploring the market by adopting expansions, investments, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Influencing Trend:
Growing Demand for Technological Advanced Immunochemistry Technologies

Market Growth Drivers:
Increased Applications of Biochemistry in Life Science and Increased Prevalence of Numerous Diseases such as Cancers and Cardiovascular Diseases

Challenges:
Dearth of Skilled Professionals

Restraints:
High Degree of Consolidation

Opportunities:
Growing Number of Geriatric Population and Increasing Research and Development Activities

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Immunochemistry Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Immunochemistry Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Immunochemistry players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Immunochemistry Study Sheds Light on
— The Immunochemistry Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Immunochemistry industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Immunochemistry industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Antibodies (Primary Antibodies and Secondary Antibodies)
  • Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others)
  • Reagents (Histological Stains, Blocking sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents)
  • Kits
By Application
  • Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases)
  • Drug Testing
By End-users
  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Applications of Biochemistry in Life Science
      • 3.2.2. Increased Prevalence of Numerous Diseases such as Cancers and Cardiovascular Diseases
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Technological Advanced Immunochemistry Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunochemistry, by Type, Application, End-users and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Immunochemistry (Value)
      • 5.2.1. Global Immunochemistry by: Type (Value)
        • 5.2.1.1. Antibodies (Primary Antibodies and Secondary Antibodies)
        • 5.2.1.2. Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others)
        • 5.2.1.3. Reagents (Histological Stains, Blocking sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents)
        • 5.2.1.4. Kits
      • 5.2.2. Global Immunochemistry by: Application (Value)
        • 5.2.2.1. Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases)
        • 5.2.2.2. Drug Testing
      • 5.2.3. Global Immunochemistry by: End-users (Value)
        • 5.2.3.1. Hospitals & Diagnostic Laboratories
        • 5.2.3.2. Research Institutes
        • 5.2.3.3. Others
      • 5.2.4. Global Immunochemistry Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Immunochemistry: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Technologies, InC.
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio SB, Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton, Dickinson and Company (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck KGaA (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biocare Medical, LLC.
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Abcam plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bio-Rad Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Immunochemistry Sale, by Type, Application, End-users and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Immunochemistry (Value)
      • 7.2.1. Global Immunochemistry by: Type (Value)
        • 7.2.1.1. Antibodies (Primary Antibodies and Secondary Antibodies)
        • 7.2.1.2. Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others)
        • 7.2.1.3. Reagents (Histological Stains, Blocking sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents)
        • 7.2.1.4. Kits
      • 7.2.2. Global Immunochemistry by: Application (Value)
        • 7.2.2.1. Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases)
        • 7.2.2.2. Drug Testing
      • 7.2.3. Global Immunochemistry by: End-users (Value)
        • 7.2.3.1. Hospitals & Diagnostic Laboratories
        • 7.2.3.2. Research Institutes
        • 7.2.3.3. Others
      • 7.2.4. Global Immunochemistry Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunochemistry: by Type(USD Billion)
  • Table 2. Immunochemistry Antibodies (Primary Antibodies and Secondary Antibodies) , by Region USD Billion (2017-2022)
  • Table 3. Immunochemistry Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others) , by Region USD Billion (2017-2022)
  • Table 4. Immunochemistry Reagents (Histological Stains, Blocking sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents) , by Region USD Billion (2017-2022)
  • Table 5. Immunochemistry Kits , by Region USD Billion (2017-2022)
  • Table 6. Immunochemistry: by Application(USD Billion)
  • Table 7. Immunochemistry Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases) , by Region USD Billion (2017-2022)
  • Table 8. Immunochemistry Drug Testing , by Region USD Billion (2017-2022)
  • Table 9. Immunochemistry: by End-users(USD Billion)
  • Table 10. Immunochemistry Hospitals & Diagnostic Laboratories , by Region USD Billion (2017-2022)
  • Table 11. Immunochemistry Research Institutes , by Region USD Billion (2017-2022)
  • Table 12. Immunochemistry Others , by Region USD Billion (2017-2022)
  • Table 13. South America Immunochemistry, by Country USD Billion (2017-2022)
  • Table 14. South America Immunochemistry, by Type USD Billion (2017-2022)
  • Table 15. South America Immunochemistry, by Application USD Billion (2017-2022)
  • Table 16. South America Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 17. Brazil Immunochemistry, by Type USD Billion (2017-2022)
  • Table 18. Brazil Immunochemistry, by Application USD Billion (2017-2022)
  • Table 19. Brazil Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 20. Argentina Immunochemistry, by Type USD Billion (2017-2022)
  • Table 21. Argentina Immunochemistry, by Application USD Billion (2017-2022)
  • Table 22. Argentina Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 23. Rest of South America Immunochemistry, by Type USD Billion (2017-2022)
  • Table 24. Rest of South America Immunochemistry, by Application USD Billion (2017-2022)
  • Table 25. Rest of South America Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 26. Asia Pacific Immunochemistry, by Country USD Billion (2017-2022)
  • Table 27. Asia Pacific Immunochemistry, by Type USD Billion (2017-2022)
  • Table 28. Asia Pacific Immunochemistry, by Application USD Billion (2017-2022)
  • Table 29. Asia Pacific Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 30. China Immunochemistry, by Type USD Billion (2017-2022)
  • Table 31. China Immunochemistry, by Application USD Billion (2017-2022)
  • Table 32. China Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 33. Japan Immunochemistry, by Type USD Billion (2017-2022)
  • Table 34. Japan Immunochemistry, by Application USD Billion (2017-2022)
  • Table 35. Japan Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 36. India Immunochemistry, by Type USD Billion (2017-2022)
  • Table 37. India Immunochemistry, by Application USD Billion (2017-2022)
  • Table 38. India Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 39. South Korea Immunochemistry, by Type USD Billion (2017-2022)
  • Table 40. South Korea Immunochemistry, by Application USD Billion (2017-2022)
  • Table 41. South Korea Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 42. Taiwan Immunochemistry, by Type USD Billion (2017-2022)
  • Table 43. Taiwan Immunochemistry, by Application USD Billion (2017-2022)
  • Table 44. Taiwan Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 45. Australia Immunochemistry, by Type USD Billion (2017-2022)
  • Table 46. Australia Immunochemistry, by Application USD Billion (2017-2022)
  • Table 47. Australia Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 48. Rest of Asia-Pacific Immunochemistry, by Type USD Billion (2017-2022)
  • Table 49. Rest of Asia-Pacific Immunochemistry, by Application USD Billion (2017-2022)
  • Table 50. Rest of Asia-Pacific Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 51. Europe Immunochemistry, by Country USD Billion (2017-2022)
  • Table 52. Europe Immunochemistry, by Type USD Billion (2017-2022)
  • Table 53. Europe Immunochemistry, by Application USD Billion (2017-2022)
  • Table 54. Europe Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 55. Germany Immunochemistry, by Type USD Billion (2017-2022)
  • Table 56. Germany Immunochemistry, by Application USD Billion (2017-2022)
  • Table 57. Germany Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 58. France Immunochemistry, by Type USD Billion (2017-2022)
  • Table 59. France Immunochemistry, by Application USD Billion (2017-2022)
  • Table 60. France Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 61. Italy Immunochemistry, by Type USD Billion (2017-2022)
  • Table 62. Italy Immunochemistry, by Application USD Billion (2017-2022)
  • Table 63. Italy Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 64. United Kingdom Immunochemistry, by Type USD Billion (2017-2022)
  • Table 65. United Kingdom Immunochemistry, by Application USD Billion (2017-2022)
  • Table 66. United Kingdom Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 67. Netherlands Immunochemistry, by Type USD Billion (2017-2022)
  • Table 68. Netherlands Immunochemistry, by Application USD Billion (2017-2022)
  • Table 69. Netherlands Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 70. Rest of Europe Immunochemistry, by Type USD Billion (2017-2022)
  • Table 71. Rest of Europe Immunochemistry, by Application USD Billion (2017-2022)
  • Table 72. Rest of Europe Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 73. MEA Immunochemistry, by Country USD Billion (2017-2022)
  • Table 74. MEA Immunochemistry, by Type USD Billion (2017-2022)
  • Table 75. MEA Immunochemistry, by Application USD Billion (2017-2022)
  • Table 76. MEA Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 77. Middle East Immunochemistry, by Type USD Billion (2017-2022)
  • Table 78. Middle East Immunochemistry, by Application USD Billion (2017-2022)
  • Table 79. Middle East Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 80. Africa Immunochemistry, by Type USD Billion (2017-2022)
  • Table 81. Africa Immunochemistry, by Application USD Billion (2017-2022)
  • Table 82. Africa Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 83. North America Immunochemistry, by Country USD Billion (2017-2022)
  • Table 84. North America Immunochemistry, by Type USD Billion (2017-2022)
  • Table 85. North America Immunochemistry, by Application USD Billion (2017-2022)
  • Table 86. North America Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 87. United States Immunochemistry, by Type USD Billion (2017-2022)
  • Table 88. United States Immunochemistry, by Application USD Billion (2017-2022)
  • Table 89. United States Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 90. Canada Immunochemistry, by Type USD Billion (2017-2022)
  • Table 91. Canada Immunochemistry, by Application USD Billion (2017-2022)
  • Table 92. Canada Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 93. Mexico Immunochemistry, by Type USD Billion (2017-2022)
  • Table 94. Mexico Immunochemistry, by Application USD Billion (2017-2022)
  • Table 95. Mexico Immunochemistry, by End-users USD Billion (2017-2022)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Immunochemistry: by Type(USD Billion)
  • Table 107. Immunochemistry Antibodies (Primary Antibodies and Secondary Antibodies) , by Region USD Billion (2023-2028)
  • Table 108. Immunochemistry Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others) , by Region USD Billion (2023-2028)
  • Table 109. Immunochemistry Reagents (Histological Stains, Blocking sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents) , by Region USD Billion (2023-2028)
  • Table 110. Immunochemistry Kits , by Region USD Billion (2023-2028)
  • Table 111. Immunochemistry: by Application(USD Billion)
  • Table 112. Immunochemistry Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases) , by Region USD Billion (2023-2028)
  • Table 113. Immunochemistry Drug Testing , by Region USD Billion (2023-2028)
  • Table 114. Immunochemistry: by End-users(USD Billion)
  • Table 115. Immunochemistry Hospitals & Diagnostic Laboratories , by Region USD Billion (2023-2028)
  • Table 116. Immunochemistry Research Institutes , by Region USD Billion (2023-2028)
  • Table 117. Immunochemistry Others , by Region USD Billion (2023-2028)
  • Table 118. South America Immunochemistry, by Country USD Billion (2023-2028)
  • Table 119. South America Immunochemistry, by Type USD Billion (2023-2028)
  • Table 120. South America Immunochemistry, by Application USD Billion (2023-2028)
  • Table 121. South America Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 122. Brazil Immunochemistry, by Type USD Billion (2023-2028)
  • Table 123. Brazil Immunochemistry, by Application USD Billion (2023-2028)
  • Table 124. Brazil Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 125. Argentina Immunochemistry, by Type USD Billion (2023-2028)
  • Table 126. Argentina Immunochemistry, by Application USD Billion (2023-2028)
  • Table 127. Argentina Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 128. Rest of South America Immunochemistry, by Type USD Billion (2023-2028)
  • Table 129. Rest of South America Immunochemistry, by Application USD Billion (2023-2028)
  • Table 130. Rest of South America Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 131. Asia Pacific Immunochemistry, by Country USD Billion (2023-2028)
  • Table 132. Asia Pacific Immunochemistry, by Type USD Billion (2023-2028)
  • Table 133. Asia Pacific Immunochemistry, by Application USD Billion (2023-2028)
  • Table 134. Asia Pacific Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 135. China Immunochemistry, by Type USD Billion (2023-2028)
  • Table 136. China Immunochemistry, by Application USD Billion (2023-2028)
  • Table 137. China Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 138. Japan Immunochemistry, by Type USD Billion (2023-2028)
  • Table 139. Japan Immunochemistry, by Application USD Billion (2023-2028)
  • Table 140. Japan Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 141. India Immunochemistry, by Type USD Billion (2023-2028)
  • Table 142. India Immunochemistry, by Application USD Billion (2023-2028)
  • Table 143. India Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 144. South Korea Immunochemistry, by Type USD Billion (2023-2028)
  • Table 145. South Korea Immunochemistry, by Application USD Billion (2023-2028)
  • Table 146. South Korea Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 147. Taiwan Immunochemistry, by Type USD Billion (2023-2028)
  • Table 148. Taiwan Immunochemistry, by Application USD Billion (2023-2028)
  • Table 149. Taiwan Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 150. Australia Immunochemistry, by Type USD Billion (2023-2028)
  • Table 151. Australia Immunochemistry, by Application USD Billion (2023-2028)
  • Table 152. Australia Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 153. Rest of Asia-Pacific Immunochemistry, by Type USD Billion (2023-2028)
  • Table 154. Rest of Asia-Pacific Immunochemistry, by Application USD Billion (2023-2028)
  • Table 155. Rest of Asia-Pacific Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 156. Europe Immunochemistry, by Country USD Billion (2023-2028)
  • Table 157. Europe Immunochemistry, by Type USD Billion (2023-2028)
  • Table 158. Europe Immunochemistry, by Application USD Billion (2023-2028)
  • Table 159. Europe Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 160. Germany Immunochemistry, by Type USD Billion (2023-2028)
  • Table 161. Germany Immunochemistry, by Application USD Billion (2023-2028)
  • Table 162. Germany Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 163. France Immunochemistry, by Type USD Billion (2023-2028)
  • Table 164. France Immunochemistry, by Application USD Billion (2023-2028)
  • Table 165. France Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 166. Italy Immunochemistry, by Type USD Billion (2023-2028)
  • Table 167. Italy Immunochemistry, by Application USD Billion (2023-2028)
  • Table 168. Italy Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 169. United Kingdom Immunochemistry, by Type USD Billion (2023-2028)
  • Table 170. United Kingdom Immunochemistry, by Application USD Billion (2023-2028)
  • Table 171. United Kingdom Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 172. Netherlands Immunochemistry, by Type USD Billion (2023-2028)
  • Table 173. Netherlands Immunochemistry, by Application USD Billion (2023-2028)
  • Table 174. Netherlands Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 175. Rest of Europe Immunochemistry, by Type USD Billion (2023-2028)
  • Table 176. Rest of Europe Immunochemistry, by Application USD Billion (2023-2028)
  • Table 177. Rest of Europe Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 178. MEA Immunochemistry, by Country USD Billion (2023-2028)
  • Table 179. MEA Immunochemistry, by Type USD Billion (2023-2028)
  • Table 180. MEA Immunochemistry, by Application USD Billion (2023-2028)
  • Table 181. MEA Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 182. Middle East Immunochemistry, by Type USD Billion (2023-2028)
  • Table 183. Middle East Immunochemistry, by Application USD Billion (2023-2028)
  • Table 184. Middle East Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 185. Africa Immunochemistry, by Type USD Billion (2023-2028)
  • Table 186. Africa Immunochemistry, by Application USD Billion (2023-2028)
  • Table 187. Africa Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 188. North America Immunochemistry, by Country USD Billion (2023-2028)
  • Table 189. North America Immunochemistry, by Type USD Billion (2023-2028)
  • Table 190. North America Immunochemistry, by Application USD Billion (2023-2028)
  • Table 191. North America Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 192. United States Immunochemistry, by Type USD Billion (2023-2028)
  • Table 193. United States Immunochemistry, by Application USD Billion (2023-2028)
  • Table 194. United States Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 195. Canada Immunochemistry, by Type USD Billion (2023-2028)
  • Table 196. Canada Immunochemistry, by Application USD Billion (2023-2028)
  • Table 197. Canada Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 198. Mexico Immunochemistry, by Type USD Billion (2023-2028)
  • Table 199. Mexico Immunochemistry, by Application USD Billion (2023-2028)
  • Table 200. Mexico Immunochemistry, by End-users USD Billion (2023-2028)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunochemistry: by Type USD Billion (2017-2022)
  • Figure 5. Global Immunochemistry: by Application USD Billion (2017-2022)
  • Figure 6. Global Immunochemistry: by End-users USD Billion (2017-2022)
  • Figure 7. South America Immunochemistry Share (%), by Country
  • Figure 8. Asia Pacific Immunochemistry Share (%), by Country
  • Figure 9. Europe Immunochemistry Share (%), by Country
  • Figure 10. MEA Immunochemistry Share (%), by Country
  • Figure 11. North America Immunochemistry Share (%), by Country
  • Figure 12. Global Immunochemistry share by Players 2022 (%)
  • Figure 13. Global Immunochemistry share by Players (Top 3) 2022(%)
  • Figure 14. Global Immunochemistry share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Thermo Fisher Scientific, Inc Revenue, Net Income and Gross profit
  • Figure 17. Thermo Fisher Scientific, Inc Revenue: by Geography 2022
  • Figure 18. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2022
  • Figure 20. Agilent Technologies, InC. Revenue, Net Income and Gross profit
  • Figure 21. Agilent Technologies, InC. Revenue: by Geography 2022
  • Figure 22. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 23. Danaher (United States) Revenue: by Geography 2022
  • Figure 24. Bio SB, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 25. Bio SB, Inc (United States) Revenue: by Geography 2022
  • Figure 26. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 27. Becton, Dickinson and Company (United States) Revenue: by Geography 2022
  • Figure 28. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 30. Biocare Medical, LLC. Revenue, Net Income and Gross profit
  • Figure 31. Biocare Medical, LLC. Revenue: by Geography 2022
  • Figure 32. Abcam plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Abcam plc (United Kingdom) Revenue: by Geography 2022
  • Figure 34. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 35. Bio-Rad Laboratories (United States) Revenue: by Geography 2022
  • Figure 36. Global Immunochemistry: by Type USD Billion (2023-2028)
  • Figure 37. Global Immunochemistry: by Application USD Billion (2023-2028)
  • Figure 38. Global Immunochemistry: by End-users USD Billion (2023-2028)
  • Figure 39. South America Immunochemistry Share (%), by Country
  • Figure 40. Asia Pacific Immunochemistry Share (%), by Country
  • Figure 41. Europe Immunochemistry Share (%), by Country
  • Figure 42. MEA Immunochemistry Share (%), by Country
  • Figure 43. North America Immunochemistry Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies, InC.
  • Danaher (United States)
  • Bio SB, Inc (United States)
  • Becton, Dickinson and Company (United States)
  • Merck KGaA (Germany)
  • Biocare Medical, LLC.
  • Abcam plc (United Kingdom)
  • Bio-Rad Laboratories (United States)
Additional players considered in the study are as follows:
PerkinElmer, Inc. , PHC Holdings Corporation (Japan)
Select User Access Type

Key Highlights of Report


May 2023 158 Pages 71 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Immunochemistry Market Quantitative research analysis
Global Immunochemistry Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Immunochemistry Market are Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, InC., Danaher (United States), Bio SB, Inc (United States), Becton, Dickinson and Company (United States), Merck KGaA (Germany), Biocare Medical, LLC., Abcam plc (United Kingdom) and Bio-Rad Laboratories (United States) etc.
Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases) segment in Global market to hold robust market share owing to "Increased Applications of Biochemistry in Life Science ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Immunochemistry market throughout the forecasted period.

Know More About Global Immunochemistry Market Report?

Have a Query? Click Here

Other Related Reports

Biological Wastewater Treatment Comprehensive Study by End-users (Municipal, Industrial (Pulp & Paper, Meat & Poultry, Chemicals, Pharmaceuticals, Others)), Process (Aerobic, Anaerobic) Players and R...
$ 3500
Cell-Surface Markers Comprehensive Study by Type (Antibody, PCR Array), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology), Hospitals), Reagent Type (Flow Cytometer, Hemat...
$ 3450
Forensic science Comprehensive Study by Type (Automated Liquid Handling Technology, Capillary Electrophoresis, Polymerase Chain Reaction (PCR), Next Generation Sequencing, Rapid DNA Analysis, Microar...
$ 3750
Coagulation Reagent Comprehensive Study by Type (APTT, D-Dimer, Fibrinogen, Prothrombin, Others), Application (Hospitals, Research Institutes, Diagnostic Centers, Others), Technology (Mechanical, Ele...
$ 3650
Biological Sample Handling Comprehensive Study by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, Others), Sample Type (Blood and Blood Fractions...
$ 3750
Biofilms Treatment Comprehensive Study by Type (Biofilm Disruptors, Antimicrobial Treatments, Antibiotic Medication, Photo Inactivation, Others), Application (Hospitals, ASCs, and Wound Care Centers,...
$ 3750